January 23, 2018
Rose
Bio-Optronics — a producer of software and services focused on clinical research, automated scheduling, and patient safety — has announced $30 million in funding from growth equity firm Mainsail Partners.
from MobiHealthNews http://ift.tt/2E3bkVW
January 23, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Senate confirms Azar for HHS director and other digital health hires- toSense's remote patient monitoring necklace gets FDA clearance to measure stroke volume and cardiac output
- To entice Pebble users to Ionic, Fitbit offers six more months of support, $50 discount
- Remote patient monitoring startup LindaCare lands $8.6M from Phillips, others
- Smartinhaler maker Adherium heads to the US market with D2C push
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment